Short-Interval ctDNA Testing Rapid Monitoring of Tumor Response in GI Cancer – Sakti Chakrabarti, MD ASCO GI Gastrointestinal 2 Mins Read Abstract: Circulating tumor DNA (ctDNA) has a short half-life (<2 hours) which may permit real-time monitoring of tumor status. This…
Breast Cancer Genetic Testing – Should Doctors Use ctDNA? Nathalie McDowell Johnson, MD Breast 3 Mins Read Dr. Nathalie M. Johnson, MD, a breast cancer specialist with Legacy Health Partners, delves into the evolving role of circulating…